Grantham Mayo Van Otterloo & Co. LLC Has $3.89 Million Position in The Allstate Co. (NYSE:ALL)

Grantham Mayo Van Otterloo & Co. LLC lifted its position in The Allstate Co. (NYSE:ALL - Free Report) by 231.8% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 20,149 shares of the insurance provider's stock after acquiring an additional 14,077 shares during the period. Grantham Mayo Van Otterloo & Co. LLC's holdings in Allstate were worth $3,885,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also bought and sold shares of ALL. Apella Capital LLC grew its position in shares of Allstate by 1.9% in the 4th quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider's stock valued at $623,000 after purchasing an additional 60 shares during the period. Intrust Bank NA lifted its stake in Allstate by 0.5% in the fourth quarter. Intrust Bank NA now owns 12,135 shares of the insurance provider's stock valued at $2,340,000 after buying an additional 61 shares in the last quarter. Perigon Wealth Management LLC increased its position in shares of Allstate by 2.1% during the fourth quarter. Perigon Wealth Management LLC now owns 2,990 shares of the insurance provider's stock worth $571,000 after acquiring an additional 62 shares in the last quarter. Mather Group LLC. increased its position in shares of Allstate by 1.7% during the fourth quarter. Mather Group LLC. now owns 3,616 shares of the insurance provider's stock worth $697,000 after acquiring an additional 62 shares in the last quarter. Finally, Angeles Wealth Management LLC raised its holdings in shares of Allstate by 4.6% during the fourth quarter. Angeles Wealth Management LLC now owns 1,403 shares of the insurance provider's stock worth $270,000 after acquiring an additional 62 shares during the period. Institutional investors own 76.47% of the company's stock.

Remove Ads

Insider Transactions at Allstate

In other Allstate news, CFO Jesse E. Merten sold 40,102 shares of the company's stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total value of $7,480,226.06. Following the transaction, the chief financial officer now directly owns 18,115 shares of the company's stock, valued at $3,378,990.95. This represents a 68.88 % decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Corporate insiders own 1.80% of the company's stock.

Wall Street Analysts Forecast Growth

A number of equities analysts recently weighed in on ALL shares. Keefe, Bruyette & Woods reduced their target price on shares of Allstate from $240.00 to $228.00 and set an "outperform" rating for the company in a research note on Wednesday. StockNews.com raised Allstate from a "hold" rating to a "buy" rating in a research report on Tuesday, April 8th. Argus raised Allstate from a "hold" rating to a "buy" rating in a research report on Monday, March 3rd. Barclays reduced their price target on Allstate from $183.00 to $172.00 and set an "underweight" rating for the company in a research report on Friday. Finally, JPMorgan Chase & Co. lifted their price objective on shares of Allstate from $217.00 to $222.00 and gave the company an "overweight" rating in a report on Tuesday, April 8th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and an average target price of $219.27.

Allstate Stock Performance

Shares of ALL stock traded up $1.79 during trading on Friday, reaching $192.58. 1,876,905 shares of the company's stock were exchanged, compared to its average volume of 1,619,636. The Allstate Co. has a twelve month low of $156.66 and a twelve month high of $212.91. The firm's fifty day moving average price is $196.82 and its 200-day moving average price is $194.22. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The stock has a market capitalization of $51.04 billion, a PE ratio of 11.33, a PEG ratio of 1.01 and a beta of 0.36.

Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. As a group, sell-side analysts anticipate that The Allstate Co. will post 18.74 EPS for the current year.

Allstate declared that its board has approved a stock buyback plan on Wednesday, February 26th that allows the company to repurchase $1.50 billion in outstanding shares. This repurchase authorization allows the insurance provider to repurchase up to 3% of its stock through open market purchases. Stock repurchase plans are typically a sign that the company's board believes its stock is undervalued.

Allstate Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, April 1st. Shareholders of record on Monday, March 10th were given a dividend of $1.00 per share. The ex-dividend date of this dividend was Monday, March 10th. This is an increase from Allstate's previous quarterly dividend of $0.92. This represents a $4.00 annualized dividend and a yield of 2.08%. Allstate's dividend payout ratio (DPR) is 23.54%.

Allstate Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.